- Home
- SDGR vs CERT Comparison
SDGR vs CERT Comparison
Compare SDGR & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDGR
- CERT
- Stock Information
- Founded
- SDGR 1990
- CERT 2008
- Country
- SDGR United States
- CERT United States
- Employees
- SDGR N/A
- CERT N/A
- Industry
- SDGR Biotechnology: Pharmaceutical Preparations
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- SDGR Health Care
- CERT Technology
- Exchange
- SDGR Nasdaq
- CERT Nasdaq
- Market Cap
- SDGR 1.7B
- CERT 1.9B
- IPO Year
- SDGR 2020
- CERT 2020
- Fundamental
- Price
- SDGR $20.46
- CERT $10.54
- Analyst Decision
- SDGR Buy
- CERT Buy
- Analyst Count
- SDGR 5
- CERT 6
- Target Price
- SDGR $32.80
- CERT $15.60
- AVG Volume (30 Days)
- SDGR 1.2M
- CERT 1.7M
- Earning Date
- SDGR 07-30-2025
- CERT 08-05-2025
- Dividend Yield
- SDGR N/A
- CERT N/A
- EPS Growth
- SDGR N/A
- CERT N/A
- EPS
- SDGR N/A
- CERT N/A
- Revenue
- SDGR $230,492,000.00
- CERT $394,498,000.00
- Revenue This Year
- SDGR $24.44
- CERT $11.57
- Revenue Next Year
- SDGR $22.17
- CERT $8.93
- P/E Ratio
- SDGR N/A
- CERT N/A
- Revenue Growth
- SDGR 22.29
- CERT 9.37
- 52 Week Low
- SDGR $16.60
- CERT $8.64
- 52 Week High
- SDGR $28.47
- CERT $16.93
- Technical
- Relative Strength Index (RSI)
- SDGR 37.57
- CERT 35.72
- Support Level
- SDGR $20.90
- CERT $10.41
- Resistance Level
- SDGR $21.62
- CERT $12.41
- Average True Range (ATR)
- SDGR 1.37
- CERT 0.52
- MACD
- SDGR -0.35
- CERT -0.10
- Stochastic Oscillator
- SDGR 4.46
- CERT 7.20
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.